<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>UNLABELLED: BACKGROUND: Matrix metalloproteinases (MMPs) play a role in <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">cancer progression</z:e> by degrading extracellular matrix and basement membranes, assisting in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> neovascularization and in supporting immune response in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We studied the prognostic value of immunohistochemical expression of MMP-2, MMP-8, and MMP-9 in a series of 619 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients using tissue microarray specimens </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Of the samples, 56% were positive for MMP-2, 78% for MMP-8, and 60% for MMP-9 </plain></SENT>
<SENT sid="3" pm="."><plain>MMP-9 associated with low WHO grade (p &lt; 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>In univariate analysis of Dukes' B <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e>, MMP-9 negativity associated with poor survival (p = 0.018), and MMP-9 positivity was an independent prognostic marker in multivariate analysis of these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> (p = 0.034) </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: Negative MMP-9 expression can predict poor prognosis in Dukes' B <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumours</z:e> and may prove useful for identifying patients, who should be offered adjuvant treatment </plain></SENT>
</text></document>